Early stage biotech developing novel exosome therapeutics for cancers.
Industry: Health Care
First Day Return: -19.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/09/2020 |
Offer Price | $15.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 5.5 |
Deal Size ($mm) | $83 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/13/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $83 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Cambridge, MA, United States |
Founded | 2015 |
Employees at IPO | 101 |
Website www.codiakbio.com |